Brian Baker
2021
In 2021, Brian Baker earned a total compensation of $1.8M as Former Senior Vice President, Finance and Administration at Turning Point Therapeutics.
Compensation breakdown
| Option Awards | $641,381 |
|---|---|
| Salary | $115,894 |
| Stock Awards | $1,005,217 |
| Other | $11,101 |
| Total | $1,773,593 |
Baker received $1M in stock awards, accounting for 57% of the total pay in 2021.
Baker also received $641.4K in option awards, $115.9K in salary and $11.1K in other compensation.
Rankings
In 2021, Brian Baker's compensation ranked 6,525th out of 12,406 executives tracked by ExecPay. In other words, Baker earned more than 47.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,525 out of 12,406 | 47th |
Division Manufacturing | 2,801 out of 5,492 | 49th |
Major group Chemicals And Allied Products | 1,237 out of 2,368 | 48th |
Industry group Drugs | 1,103 out of 2,089 | 47th |
Industry Pharmaceutical Preparations | 799 out of 1,536 | 48th |
Source: SEC filing on April 29, 2022.
Baker's colleagues
We found six more compensation records of executives who worked with Brian Baker at Turning Point Therapeutics in 2021.
2021
Athena Countouriotis
Turning Point Therapeutics
Chief Executive Officer
2021
Mohammad Hirmand
Turning Point Therapeutics
Chief Medical Officer
2021
Annette North
Turning Point Therapeutics
General Counsel
2021
Paolo Tombesi
Turning Point Therapeutics
Chief Financial Officer
2021
Siegfried PHD
Turning Point Therapeutics
Chief Scientific Officer
2021
Yi Larson
Turning Point Therapeutics